Phosphate control in reducing FGF23 levels in hemodialysis patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphate control in reducing FGF23 levels in hemodialysis patients
Authors
Keywords
Phosphates, Medical dialysis, Fibroblast growth factor, Inflammation, Ferritin, Vitamin D, Parathyroid hormone, Linear regression analysis
Journal
PLoS One
Volume 13, Issue 8, Pages e0201537
Publisher
Public Library of Science (PLoS)
Online
2018-08-08
DOI
10.1371/journal.pone.0201537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
- (2017) Markus Ketteler et al. KIDNEY INTERNATIONAL
- High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
- (2017) Hirokazu Honda et al. PLoS One
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
- (2016) Saurav Singh et al. KIDNEY INTERNATIONAL
- The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial
- (2015) Peter N. Van Buren et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism
- (2015) S. M. Sprague et al. Clinical Journal of the American Society of Nephrology
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study
- (2015) Romina di Giuseppe et al. PLoS One
- Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients
- (2014) Bernhard O. Bielesz et al. CLINICAL BIOCHEMISTRY
- Coupling fibroblast growth factor 23 production and cleavage
- (2014) Myles Wolf et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription
- (2014) Tomer Meir et al. KIDNEY INTERNATIONAL
- Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients
- (2014) Hsin-Hung Lin et al. NEPHROLOGY
- Laboratory Abnormalities in CKD-MBD: Markers, Predictors, or Mediators of Disease?
- (2014) Pieter Evenepoel et al. SEMINARS IN NEPHROLOGY
- Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
- (2013) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients
- (2013) Sagrario Soriano et al. CLINICAL NEPHROLOGY
- Calcium Regulates FGF-23 Expression in Bone
- (2013) Valentin David et al. ENDOCRINOLOGY
- Fibroblast growth factor-23: what we know, what we don't know, and what we need to know
- (2013) C. P. Kovesdy et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease
- (2013) Makoto Kuro-o Kidney International Supplements
- Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo
- (2012) Stephen J. Quinn et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fibroblast Growth Factor 23 and Inflammation in CKD
- (2012) J. Munoz Mendoza et al. Clinical Journal of the American Society of Nephrology
- Calcium Deficiency Reduces Circulating Levels of FGF23
- (2012) M. E. Rodriguez-Ortiz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- FGF23 and PTH--double agents at the heart of CKD
- (2012) J. Silver et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis
- (2011) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- Effect of Phosphate Binders on Serum Inflammatory Profile, Soluble CD14, and Endotoxin Levels in Hemodialysis Patients
- (2011) J. F. Navarro-Gonzalez et al. Clinical Journal of the American Society of Nephrology
- Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
- (2011) Ignacio López et al. KIDNEY INTERNATIONAL
- Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study)
- (2011) T. Shigematsu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
- (2011) M. Koizumi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Phosphate toxicity: new insights into an old problem
- (2010) M. Shawkat Razzaque CLINICAL SCIENCE
- Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro
- (2010) Yolanda Almaden et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Elevated FGF23 Levels Are Associated with Impaired Calcium-Mediated Suppression of PTH in ESRD
- (2010) James B. Wetmore et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 Fails to Inhibit Uremic Parathyroid Glands
- (2010) R. Canalejo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
- (2010) M. Wolf JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study
- (2010) V. M. Brandenburg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
- (2010) H. Olauson et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 in Hemodialysis Patients: Effects of Phosphate Binder, Calcitriol and Calcium Concentration in the Dialysate
- (2010) Ana L.E. Cancela et al. NEPHRON CLINICAL PRACTICE
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Mineral Metabolism and Inflammation in Chronic Kidney Disease Patients: A Cross-Sectional Study
- (2009) J. F. Navarro-Gonzalez et al. Clinical Journal of the American Society of Nephrology
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease
- (2009) H. Galitzer et al. KIDNEY INTERNATIONAL
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now